Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$48,221 | -$38,273 | -$36,638 | -$33,029 |
| Dep. & Amort. | $220 | $213 | $342 | $1,075 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,586 | $0 | $4,965 |
| Change in WC | $3,029 | -$9,888 | -$3,407 | -$5,551 |
| Other Non-Cash | $8,805 | -$1,699 | -$21 | -$2,941 |
| Operating Cash Flow | -$36,167 | -$47,061 | -$39,724 | -$35,481 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$53 | -$26 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$29,586 | -$75,521 | -$101,012 | -$83,684 |
| Inv. Sales/Matur. | $46,600 | $119,700 | $123,100 | $136,900 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,014 | $44,126 | $22,062 | $53,216 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,872 | $94 | $504 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1,872 | $94 | $504 | $0 |
| Forex Effect | -$95 | $129 | $105 | -$125 |
| Net Chg. in Cash | -$17,376 | -$2,712 | -$17,053 | $17,610 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,309 | $29,021 | $46,074 | $28,464 |
| End Cash | $8,933 | $26,309 | $29,021 | $46,074 |
| Free Cash Flow | -$36,167 | -$47,114 | -$39,750 | -$35,481 |